breast cancer Flashcards

1
Q

age

A
  1. Increased number of mutagenic changes over a long lifespan
  2. Increased number of older women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

familial history

A

Accounts for 5-10% of cases (BRCA I & BRCA II genes)

Earlier onset than non-inherited breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Gender

A
  1. 99% of cases are women

2. 1% of cases are men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Menstrual history

A
  1. Early menarche, late menopause
  2. Nulliparous or 1st child after age 30
    (Earlier breast development with pregnancy protects from cancer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

hormone therapy

A

Menopausal Hormone Therapy (MHT) following menopause shows slight increases risk for reproductive cancers (breast cancer) and CAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

obesity

A
  1. Especially after menopause

2. Can cause stimulating effect on breast cancer growth (estrogen stored in adipose tissue)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

radiation exposure

A

Survivors of Hiroshima show increased cancers, including breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

previous risk of breast cancer

A

Increased risk of cancers in the opposite breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Benign breast disease

A

Fibrocystic disease NOT associated with breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

epidemiology

A

Most Common Cancer in Women: Accounts for about 1/3 of all cancers in women; Approx. 1 in 8 chance of developing
Worldwide problem: Highest in US, Western Europe
Incidence rates have increased since 1980s, while deaths have decreased
Breast Cancer in Blacks: Often diagnosed later, poorer survival rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

prognostic indicators

A

Staging: according to TNM
Tumor size: 2 cm or less without nodes has best prognosis
Increased axillary node involvement increases risk of distant metastases
Cell Activity:
Fraction of tumor cells in synthesis phase: fast growing with poorer prognosis
Improved prognosis if 10 or more receptors on cell for estrogen (ER+) or progesterone (PR+)
These tumors respond to hormonal manipulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

breast comprised of

A

Ducts (milk producing glands)
Lobules (milk passageways)
Stroma: Fatty tissues and ligaments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

carcinomas

A

Tumors arise in ductal or lobular tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

carcinoma in situ

A

When confined to lobule or duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DCIS Ductal carcinoma in situ

A

most common
Pre-cancerous
Found on mammogram
Non invasive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

breast cancer can be divided into 4 quadrants

A

Upper outer quadrant most common site for cancer

17
Q

clinical manifestations

malignant

A
  1. Shape more difficult to define
  2. Less mobile (becomes fixed to chest wall)
  3. Can cause retraction and dimpling
18
Q

clinical manifestations

benign

A
  1. Well defined edges
  2. Encapsulated
  3. Freely moveable
19
Q

characteristics of nipples

A

pain, scaly-ness ulceration, retraction/deviation at odd angle, or spontaneous discharge

20
Q

dimpling of skin

A

Peau d’orange appearance

21
Q

lump

A

irregular, star shaped

often not tender

22
Q

mammography

A
  1. Can detect breast cancers before they are palpable
  2. Cannot always differentiate malignant from benign
  3. Not 100% guarantee
23
Q

clinical breast exam

A

ACS (American Cancer Society) recommends annual mammogram and clinical breast exam for women past age 40yrs.

24
Q

breast ultrasound

A

Can determine size, differentiate fluid filled cyst from solid lesion

25
Q

breast biopsies

A

Fine needle aspiration: cysts vs. solid tumors
Core biopsy: takes tissue sample
Incisional removes some of tumor
Excisional removes all of tumor

26
Q

diagnostics to determine metastasis

A
  1. Bone Scan
  2. Bone Marrow Biopsy
  3. Liver Scan
  4. CXR- chest x-ray
  5. Other
27
Q

surgical removal is the mainstay

A

Localized disease: lumpectomy with removal of tumor and margin of tissue; separate incision to determine nodal involvement

28
Q

sentinel node biopsy

A

inject radioactive dye or blue dye near tumor; identify first node or “sentinel” node to contain dye
- Fewer nodes removed for pathology

29
Q

mastectomy

A

Simple: removal of breast
Modified radical: removal of breast and lymph nodes
Radical: removal of breast, nodes, and muscle

30
Q

postoperative care

A
  1. Arm on affected side: movement limited for 24 hours; Hand exercises may be started
  2. Elevate arm on affected side- to promote venous return
  3. Jackson Pratt drain may be placed if lymph nodes or tissue removed
  4. TEACH: no BPs, injections, watches, lifting on affected side
  5. Avoid burns, injuries to affected side- trauma wont drain well
    RATIONALE: avoid trauma that may lead to infection when lymph removed
31
Q

lymphedema

A
  1. Lymph system is a one way vascular system to drain interstitial tissue fluid back to venous system
  2. Occurs with increased removal of nodes/tissues
32
Q

radiation

A
  1. Standard use following lumpectomy (5-6 weeks) to irradiate any remaining cells
  2. May be used pre-op for large tumors
  3. Requires close follow-up
  4. SE: redness, dryness, itching, edema, tenderness, and fatigue (bone marrow suppression)
33
Q

hormonal therapy

A
  1. Competes for estradiol binding sites on ER+ cells
  2. Greatest benefit in women past age 50
  3. Decreases recurrence rate
34
Q

hormonal therapy side effects

A
  1. Hot flashes
  2. Nausea
  3. Fluid Retention
  4. Vaginal Discharge
  5. Increased risk of endometrial cancer
  6. Amenorrhea
35
Q

area of metastases

A
  1. Bone
  2. Lung
  3. Liver
  4. Brain
36
Q

treatment for advanced disease

A

Palliative Radiation for areas of metastases

37
Q

Recurrence of breast cancer

A
  1. Usually within 2-8 years

2. The earlier the recurrence, the graver the prognosis